Addressing unmet need of Filipino patients remain to be at the forefront of our company’s objectives. Wellesta Buergli Inc. has partnered with Wortham Laboratories to launch SeraSealTM, an innovative hemostatic agent that aims to reduce bleeding rates, in-hospital mortality and decrease healthcare costs